Piperlongumine Triggers Reactive Oxygen Species Driven Mitochondrial Dysfunction Leading to Apoptosis in Human Colon Cancer Cells
BioFactors · 2025-11 · 51 (6)
DOI: 10.1002/biof.70050 ↗Kurz gefasst
Fachartikel in der Zeitschrift BioFactors, online erschienen am 31.10.2025. Verfasst von Rajeev Kumar Sahoo und 7 weiteren Autor:innen. Beteiligte Einrichtung: Cancer Drug Resistance Laboratory, Department of Life Science, National Institute of Technology Rourkela, India. Hauptthemen laut MEDLINE: Dioxolanes, Reactive Oxygen Species, Apoptosis, Colonic Neoplasms. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 51 Literaturangaben.
Abstract (Originalsprache)
Prolonged use of conventional chemotherapy has led to adverse side effects and drug resistance, leading to therapeutic failure in colon cancer patients. An alternative therapy involving natural products with least toxicity can show promising results in cancer therapeutics. A bioactive alkaloid Piperlongumine (PIP), found in our culinary spice, exhibits potential pharmacological relevance, especially regarding its anticancer effects. This study is an original research work examining the anticancer efficacy of PIP and its related molecular mechanisms in human colon cancer cells. The results revealed that PIP induces selective cytotoxicity against colon cancer cells while inhibiting proliferation, migration and invasion. PIP also builds up reactive oxygen species (ROS) that increase the oxidative stress of the cells leading to disruption of the mitochondrial membrane and loss of mitochondrial membrane potential. In addition, PIP induces cell cycle arrest at the G 2 /M phase of the cell cycle and impedes the epithelial‐to‐mesenchymal transition in colon cancer cells. Further, PIP‐mediated elevated intracellular ROS induces DNA damage and activates the caspase‐dependent apoptotic pathway in colon cancer cells. PIP also reports an anti‐tumorigenic effect on the multicellular tumor spheroids of colon cancer cells. Collectively, these findings validate that PIP shows promising anticancer potential towards colon cancer cells and is a potential candidate for use in combination with existing anticancer drugs.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Cancer Drug Resistance Laboratory, Department of Life Science, National Institute of Technology Rourkela, India.
- Eshelman School of Pharmacy, Division of Pharmacotherapy and Experimental Therapeutics, University of North Carolina at Chapel Hill, North Carolina, USA.
- Department of Bioinformatics, Central University of South Bihar, Gaya, India.
ORCID-Profile: Rajeev Kumar Sahoo, Surya Kant Tripathi, Sambit Kumar Patra, Bijesh Kumar Biswal
Zitieren
APA
Sahoo, R. K., Tripathi, S. K., Barik, K., Biswal, S., Patra, S. K., Panda, S. S., Kumar, A., & Biswal, B. K. (2025). Piperlongumine Triggers Reactive Oxygen Species Driven Mitochondrial Dysfunction Leading to Apoptosis in Human Colon Cancer Cells. BioFactors, 51(6). https://doi.org/10.1002/biof.70050
Vancouver
Sahoo RK, Tripathi SK, Barik K, Biswal S, Patra SK, Panda SS, et al. Piperlongumine Triggers Reactive Oxygen Species Driven Mitochondrial Dysfunction Leading to Apoptosis in Human Colon Cancer Cells. BioFactors. 2025;51(6). doi:10.1002/biof.70050
BibTeX
@article{Sahoo2025,
author = {Sahoo, Rajeev Kumar and Tripathi, Surya Kant and Barik, Krishnendu and Biswal, Stuti and Patra, Sambit Kumar and Panda, Shikshya Swarupa and Kumar, Anil and Biswal, Bijesh Kumar},
title = {Piperlongumine Triggers Reactive Oxygen Species Driven Mitochondrial Dysfunction Leading to Apoptosis in Human Colon Cancer Cells},
journal = {BioFactors},
year = {2025},
volume = {51},
number = {6},
doi = {10.1002/biof.70050}
}
EUVIMED